These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 945166)

  • 41. Iron deficiency-induced circadian rhythm reversal of dopaminergic-mediated behaviours and thermoregulation in rats.
    Youdim MB; Yehuda S; Ben-Uriah Y
    Eur J Pharmacol; 1981 Sep; 74(4):295-301. PubMed ID: 7197630
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuroendocrine effects of neuropsychotropic drugs and their possible influence on toxic reactions in animals and man -- the role of the dopamine-prolactin system.
    Horowski R; Gräf KJ
    Arch Toxicol Suppl; 1979; (2):93-104. PubMed ID: 288372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tolerance to some behavioural effects of lisuride, a dopamine receptor agonist, and reverse tolerance to others, after repeated administration.
    Carruba MO; Ricciardi S; Chiesara E; Spano PF; Mantegazza P
    Neuropharmacology; 1985 Mar; 24(3):199-206. PubMed ID: 4039419
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Significance of dopamine receptor activity in dl-p-methoxyamphetamine- and d-amphetamine-induced locomotor activity.
    Tseng LF; Loh HH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):717-24. PubMed ID: 4858403
    [No Abstract]   [Full Text] [Related]  

  • 45. Enhancement of reserpine-elicited dopaminergic supersensitivity by repeated treatment with apomorphine and alpha-methyl-p-tyrosine.
    Friedman E; Rotrosen J; Gurland M; Lambert GA; Gershon S
    Life Sci; 1975 Sep; 17(6):867-73. PubMed ID: 1238887
    [No Abstract]   [Full Text] [Related]  

  • 46. Hypothermic effects of apomorphine homologues in mice.
    Menon MK; Clark WG; Cannon JG
    J Pharm Pharmacol; 1979 May; 31(5):318-21. PubMed ID: 37302
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A study of the role of catecholamines in the response to various central stimulants.
    Sayers AC; Handley SL
    Eur J Pharmacol; 1973 Jul; 23(1):47-55. PubMed ID: 4147437
    [No Abstract]   [Full Text] [Related]  

  • 48. 2-Bromolisuride, an ergot derivative, with dopamine antagonistic and serotonin agonistic properties.
    Fink H; Morgenstern R; Ott T
    Pharmacol Biochem Behav; 1991 Feb; 38(2):321-5. PubMed ID: 1905409
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differentiaton of neuropharmacological actions of apomorphine and d-amphetamine.
    Quock RM; Horita A
    Pharmacol Biochem Behav; 1976 Dec; 5(6):627-31. PubMed ID: 139615
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Relationship between gnawing compulsion and central dopaminergic mechanism in guinea pigs (author's transl)].
    Uemura H
    Nihon Yakurigaku Zasshi; 1979 Jan; 75(1):61-72. PubMed ID: 571393
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dopaminergic mediation of the interoceptive cue produced by d-amphetamine in rats.
    Schechter MD; Cook PG
    Psychopharmacologia; 1975 May; 42(2):185-93. PubMed ID: 240181
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differences in the nature of the stereotyped behaviour induced by aporphine derivatives in the rat and in their actions in extrapyramidal and mesolimbic brain areas.
    Costall B; Naylor RJ; Neumeyer JL
    Eur J Pharmacol; 1975 Mar; 31(1):1-16. PubMed ID: 1168579
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dopaminergic nature of amphetamine-induced pecking in pigeons.
    Cheng HC; Bhatnagar RK; Long JP
    Eur J Pharmacol; 1975; 33(2):319-24. PubMed ID: 1237409
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Substituted ergolines: potential antipsychotics with unique profile. I. Psychopharmacological characterization.
    Groó D; Palosi A
    Pol J Pharmacol Pharm; 1988; 40(6):593-601. PubMed ID: 2908363
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dopamine-like activities of an aminopyridazine derivative, CM 30366: a behavioural study.
    Worms P; Kan JP; Wermuth CG; Biziere K
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):246-52. PubMed ID: 3100965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pre- and post-synaptic actions of apomorphine: differentiation by rotatory effects in normal rats.
    Glick SD; Jerussi TP; Cox RD; Fleisher LN
    Arch Int Pharmacodyn Ther; 1977 Feb; 225(2):303-7. PubMed ID: 557962
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The partial D2-like dopamine receptor agonist terguride acts as a functional antagonist in states of high and low dopaminergic tone: evidence from preweanling rats.
    McDougall SA; Hernandez RM; Reichel CM; Farley CM
    Psychopharmacology (Berl); 2005 Apr; 178(4):431-9. PubMed ID: 15765258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Electrophysiological evaluation of a partial agonist of dopamine receptors.
    Piercey MF; Hoffmann WE; Vogelsang GD; Travis M
    J Pharmacol Exp Ther; 1987 Oct; 243(1):391-6. PubMed ID: 3668865
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic variations in midbrain dopamine cell number: parallel with differences in responses to dopaminergic agonists and in naturalistic behaviors mediated by central dopaminergic systems.
    Fink JS; Reis DJ
    Brain Res; 1981 Oct; 222(2):335-49. PubMed ID: 6116521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.